en

PRODUCT DETAIL

Everolimus Accord 10 mg tablety

Code 4142E
MA number 44/0181/23-S
Product Form: tbl 10x10 mg (blis.OPA/Al/PVC/Al)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Mutual recognition procedure
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01E Protein kinase inhibitors
L01EG Mammalian target of rapamycin (mTOR) kinase inhibitors
L01EG02 Everolimus
Shelf life: 36
Container: blister OPA/Al/PVC/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 04.08.2023
Validity: 04.08.2028
SPC: SPC_Everolimus Accord_07 2023.pdf  
PIL: PIL_Everolimus Accord_07 2023.pdf  
Safety feature Yes
Data update: 16.08.2023
eu-flag.png sk-flag.png